- Home
- MDBH vs ANEB Comparison
MDBH vs ANEB Comparison
Compare MDBH & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDBH
- ANEB
- Stock Information
- Founded
- MDBH 1997
- ANEB 2020
- Country
- MDBH United States
- ANEB United States
- Employees
- MDBH N/A
- ANEB N/A
- Industry
- MDBH
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- MDBH
- ANEB Health Care
- Exchange
- MDBH Nasdaq
- ANEB Nasdaq
- Market Cap
- MDBH 39.3M
- ANEB 39.0M
- IPO Year
- MDBH 2023
- ANEB 2021
- Fundamental
- Price
- MDBH $4.23
- ANEB $1.54
- Analyst Decision
- MDBH
- ANEB Strong Buy
- Analyst Count
- MDBH 0
- ANEB 2
- Target Price
- MDBH N/A
- ANEB $5.50
- AVG Volume (30 Days)
- MDBH 5.3K
- ANEB 7.4K
- Earning Date
- MDBH 08-12-2025
- ANEB 05-13-2025
- Dividend Yield
- MDBH N/A
- ANEB N/A
- EPS Growth
- MDBH N/A
- ANEB N/A
- EPS
- MDBH 0.84
- ANEB N/A
- Revenue
- MDBH $3,574,131.00
- ANEB N/A
- Revenue This Year
- MDBH N/A
- ANEB N/A
- Revenue Next Year
- MDBH N/A
- ANEB N/A
- P/E Ratio
- MDBH $5.02
- ANEB N/A
- Revenue Growth
- MDBH N/A
- ANEB N/A
- 52 Week Low
- MDBH $3.61
- ANEB $0.80
- 52 Week High
- MDBH $12.00
- ANEB $3.08
- Technical
- Relative Strength Index (RSI)
- MDBH 52.12
- ANEB 70.65
- Support Level
- MDBH $3.72
- ANEB $1.32
- Resistance Level
- MDBH $4.75
- ANEB $1.69
- Average True Range (ATR)
- MDBH 0.12
- ANEB 0.13
- MACD
- MDBH 0.07
- ANEB 0.05
- Stochastic Oscillator
- MDBH 49.32
- ANEB 77.88
About MDBH MDB Capital Holdings LLC common
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.